Wu Jun, Yuan Xiaohui, Wang Bing, Gu Rui, Li Wei, Xiang Xuemei, Tang Lijun, Sun Hongyu
Department of Basic Medical Sciences, The General Hospital of Western Theater Command, Chengdu, China.
College of Medicine, Southwest Jiaotong University, Chengdu, China.
Front Microbiol. 2020 Jul 3;11:1576. doi: 10.3389/fmicb.2020.01576. eCollection 2020.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory virus with high morbidity, which was named coronavirus disease 2019 (COVID-19) by World Health Organization (WHO). COVID-19 has triggered a series of threats to global public health. Even worse, new cases of COVID-19 infection are still increasing rapidly. Therefore, it is imperative that various effective vaccines and drugs should be developed to prevent and treat COVID-19 and reduce the serious impact on human beings. For this purpose, detailed information about the pathogenesis of COVID-19 at the cellular and molecular levels is urgently needed. In this review, we summarized the current understanding on gene structure, protein function, and pathogenic mechanisms of SARS-CoV-2. Based on the above, we refined the correlations among gene structure, protein function, and pathogenic mechanisms of SARS-CoV-2. Importantly, we further discussed potential therapeutic targets, aiming to accelerate the advanced design and development of vaccines and therapeutic drugs against COVID-19.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新出现的、发病率很高的呼吸道病毒,世界卫生组织(WHO)将其命名为2019冠状病毒病(COVID-19)。COVID-19对全球公共卫生构成了一系列威胁。更糟糕的是,COVID-19感染的新病例仍在迅速增加。因此,必须研发各种有效的疫苗和药物来预防和治疗COVID-19,并减轻其对人类的严重影响。为此,迫切需要有关COVID-19在细胞和分子水平发病机制的详细信息。在这篇综述中,我们总结了目前对SARS-CoV-2基因结构、蛋白质功能和致病机制的认识。基于上述内容,我们梳理了SARS-CoV-2基因结构、蛋白质功能和致病机制之间的相关性。重要的是,我们进一步讨论了潜在的治疗靶点,旨在加速针对COVID-19的疫苗和治疗药物的前期设计与开发。